Forbes interviews Jill Crandall, M.D., about resveratrol, an extract of red wine, and its potential to boost metabolism in humans. Dr. Crandall, who studies resveratrol’s effect on insulin sensitivity, notes that the research in humans is still too early and does not provide enough evidence to suggest that people take supplements. Dr. Crandall is associate professor of clinical medicine at Einstein and attending physician of endocrinology at Montefiore Medical Center.(Tuesday, June 25, 2013)
MSN features Jill Crandall, M.D., in an article that dispels some current myths about insulin therapy. Dr. Crandall notes that insulin injections can be a lifesaving therapy for both type 1 and type 2 diabetics, who cannot control the disease with diet and exercise alone, and discusses the changes in insulin delivery methods, including finer needles and injector pens, that are making insulin dosage more convenient and less painful than ever before. Dr. Crandall is associate professor of clinical medicine. (Wednesday, November 03, 2010)
U.S. News & World Report (via Science News) features Jill Crandall, M.D., and her pilot study, which indicates that resveratrol, the substance widely known to be found in red wine and thought to impart health benefits, improves insulin resistance. Dr. Crandall emphasized that while the results of her small study were promising, they are preliminary and the benefits of resveratrol remain unproven. Dr. Crandall is associate professor of clinical medicine. (Tuesday, June 29, 2010)
More coverage on this storyOrlando Sentinel
Asian News International (ANI) features research by Jill Crandall, M.D., regarding her study linking diabetes and heart disease published in the online editon of the Journal of Clinical Endocrinology & Metabolism. The study focuses on cardiovascular risk profile of older adults with pre-diabetes. Dr. Crandall is associate professor of clinical medicine. (Wednesday, March 04, 2009) read more...
More coverage on this storyThe Times of India